Hospitals are gearing up to test if a century-old treatment used to fight off flu and measles outbreaks in the days before vaccines, and tried more recently against SARS and Ebola, just might work for COVID-19, too: using blood donated from patients who’ve recovered.
When researchers at the University of Kentucky compare brains donated from people who died with dementia, very rarely do they find one that bears only Alzheimer’s trademark plaques and tangles — no other damage. That hard-won lesson helps explain how scientists are rethinking Alzheimer’s.
Cancer patients often wonder “why me?” Does their tumor run in the family? Did they try hard enough to avoid risks like smoking, too much sun or a bad diet? New research suggests random chance may play a bigger role than people realize.